arrow
Back
R

Roy S. Herbst

yale university

134H-index
1.3KPaper Count
9.3WCitation Count
Published Papers 215
Publication Date
errShare
errSave
Bridging the Gap in Lung Cancer: a comprehensive global strategy for change
err2025-10-25
err0
PREAI
errKostas N. Syrigos; Mary E. Bussell; Humaid O. Al-Shamsi; Ola M. Khorshid; Roy S. Herbst; Sofia Angelaki; Natasha Leighl; Fred Hirsch; Heather Wakelee
errShare
errSave
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer
err2025-10-10
err0
errOAAI
errThazin N. Aung; James Monkman; Jonathan Warrell; Ioannis Vathiotis; Katherine M. Bates; Niki Gavrielatou; Ioannis P. Trontzas; Chin Wee Tan; Aileen I. Fernandez; Myrto Moutafi; Ken O’ Byrne; Kurt A. Schalper; Konstantinos Syrigos; Roy S. Herbst; Arutha Kulasinghe; David L. Rimm
errShare
errSave
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024
errCancer
IF5.1
err2025-08-26
err0
PREAI
errNarjust Florez MD; Sandip Patel MD; Heather A. Wakelee MD; Julia Rotow MD; Elaine Shum MD; Jacob Sands MD; Ravi Salgia MD, PhD; Fred R. Hirsch MD, PhD; Solange Peters MD, PhD; Joshua Sabari MD; Hatim Husain MD; Lyudmila Bazhenova MD; Erminia Massarelli MD, PhD, MS; Leah M. Backhus MD, MPH; Percy Lee MD; Roy S. Herbst MD, PhD; Christine Bestvina MD; Kristin Higgins MD; Aakash Desai MD, MPH; Martin Dietrich MD, PhD; Hari Balaji Keshava MD, MS; Balazs Halmos MD, MS; David R. Gandara MD; Jonathan Wesley Riess MD, MS; Ana I. Velázquez MD, MSc; Anjali Sibley MD, MPH; Misty Shields MD, PhD; Triparna Sen PhD, MS; Edward S. Kim MD, MBA
errShare
errSave
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma
err2025-08-19
err0
errOAAI
errAmin H. Nassar; Chul Kim; Tolulope Adeyelu; Elias Bou Farhat; Hassan Abushukair; Mehrdad Rakaee; Kelsey Matteson; Shun-Fat Lau; Yamato Takabe; Antonio Ocejo; Fatemeh Ardeshir-Larijani; Ticiana Leal; Suresh Ramalingam; Sumaiya Alam; Jhanelle E. Gray; James Hicks; David Kaldas; Javier Baena; Maria Zurera Berjaga; Frank Aboubakar Nana; Christian Grohe; Heike Leuders; Fabrizio Citarella; Alessio Cortellini; Emanuele Claudio Mingo; Danny Pancirer; Millie Das; Timothy John Ellis-Caleo; Justin M. Cheung; Jessica J. Lin; Alexander S. Watson; D. Ross Camidge; Arthi Sridhar; Kaushal Parikh; Fionnuala Crowley; Thomas U. Marron; Vanya Aggarwal; Murtaza Ahmed; Kamya Sankar; Hassan Kawtharany; Jun Zhang; Dwight H. Owen; Mingjia Li; Misako Nagasaka; David J. Pinato; Nichola Awosika; Khaled Alhamad; Sonam Puri; Unaiza Zaman; Divya M. Gupta; Chelsea Lau; Hina Khan; Justin Liauw; Ana I. Velazquez; Tyiesha Brown; Laura Moliner; Miguel Mosteiro; Pedro Rocha; Mark Evans; Ari Vanderwalde; Andrew Elliott; Jorge Nieva; Gilberto Lopes; Patrick C. Ma; Hossein Borghaei; Matthew Lee; Lauren Young; Raid Aljumaily; Haris Mirza; David J. Kwiatkowski; Roy S. Herbst; Richard A. Flavell; Abdul Rafeh Naqash; Anne C. Chiang
errShare
errSave
Digital Versus Manual PD-L1 Scoring in Advanced Non-Small Cell Lung Cancer From the IMpower110 and IMpower150 Trials
err2025-08-05
err0
PREAI
errRoy S. Herbst; Hen Prizant; Daniel Ruderman; Jake Conway; John Shamshoian; Hartmut Koeppen; Wei Zou; Filippo de Marinis; Giuseppe Giaccone; Jacek Jassem; David R. Spigel; Mark A. Socinski; Martin Reck; Luciana Molinero; Marcus Ballinger; David Shames; Michael Griffin; Limin Yu; Nishant Agrawal; Andrew Beck; Ilan Wapinski; Stephanie Hennek; Jennifer Giltnane; Minu K. Srivastava
errShare
errSave
Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer: Phase 3 LEAP-006 Study
err2025-05-24
err0
PREAI
errRoy S. Herbst; Byoung Chul Cho; Caicun Zhou; Mauricio Burotto; Manuel Cobo Dols; Mehmet A.N. Sendur; Vladimir Moiseyenko; Ignacio Casarini; Makoto Nishio; Rina Hui; Elvire Pons-Tostivint; Julia Dudnik; Samreen Ahmed; Chinyere E. Okpara; Corina Dutcus; Lina Yin; Yiwen Luo; Diana Chirovsky; Niyati Bhagwati; Delvys Rodriguez Abreu
errShare
errSave
Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer
err2025-03-17
err0
errOAAI
errHerbst, Roy S.; Grohe, Christian; Kato, Terufumi; Laktionov, Konstantin; Bonanno, Laura; Tiseo, Marcello; Majem, Margarita; Domine, Manuel; Ahn, Myung-Ju; Kowalski, Dariusz M.; Perol, Maurice; Sriuranpong, Virote; Ozguroglu, Mustafa; Bhetariya, Preetida; Markovets, Aleksandra; Rukazenkov, Yuri; Muldoon, Caitlin; Robichaux, Jacqulyne; Hartmaier, Ryan; Tsuboi, Masahiro
errShare
errSave
Optimizing public-private partnerships to support clinical cancer research
err2024-12-12
err0
PREAI
errHerbst, Roy S.; Blumenthal, Gideon; Khleif, Samir N.; Lippman, Scott M.; Meropol, Neal J.; Rosati, Kristen; Shulman, Lawrence N.; Smith, Heind; Wang, Meina; Winn, Robert A.; Schilsky, Richard L.
errShare
errSave
Quantitative Measurement of HER2 Expression in Non-Small Cell Lung Cancer With a High-Sensitivity Assay
err2024-09-01
err0
PREAI
errLiu, Matthew; Vathiotis, Ioannis; Robbins, Charles J.; Chan, Nay Nwe Nyein; Moutafi, Myrto; Burela, Sneha; Xirou, Vasiliki; Schalper, Kurt A.; Herbst, Roy S.; Syrigos, Konstantinos; Rimm, David L.
errShare
errSave
A genomic scar based signature (HRDsig) and biallelic BRCA alterations identify a homologous recombination deficiency (HRD) phenotype of non-small cell lung cancer (NSCLC) potentially actionable to the PARP inhibitor rucaparib: Post-hoc analysis of lung-MAP substudy S1900A
err2024-09-01
err0
PREAI
errRiess, J. W.; Miao, J.; Wheatley-Price, P.; Reckamp, K. L.; Kozono, D.; Redman, M. W.; Edelman, M. J.; Faller, B.; Villaruz, L.; Corum, L.; Gowda, A.; Srkalovic, G.; Osarogiagbon, R.; Baumgart, M.; Gandara, D. R.; Sokol, E. S.; Borghaei, H.; Gray, J. E.; Herbst, R. S.; Kelly, K.
errShare
errSave
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
err2024-03-11
err0
errOAAI
errTsuboi, Masahiro; Herbst, Roy S.; John, Thomas; Kato, Terufumi; Majem, Margarita; Grohe, Christian; Wang, Jie; Goldman, Jonathan W.; Lu, Shun; de Marinis, Filippo; Shepherd, Frances A.; Lee, Ki Hyeong; Le, Nhieu Thi; Dechaphunkul, Arunee; Kowalski, Dariusz; Bonanno, Laura; Domine, Manuel; Poole, Lynne; Bolanos, Ana; Rukazenkov, Yuri; Wu, Yi-Long
errShare
errSave
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
err2024-03-01
err12
errOAAI
errBrahmer, Julie R.; Long, Georgina, V; Hamid, Omid; Garon, Edward B.; Herbst, Roy S.; Andre, Thierry; Armand, Philippe; Bajorin, Dean; Bellmunt, Joaquim; Burtness, Barbara; Choueiri, Toni K.; Cohen, Ezra E. W.; Diaz Jr, Luis A.; Shitara, Kohei; Kulkarni, Girish; McDermott, David; Shah, Manish; Tabernero, Josep; Vogel, Arndt; Zinzani, Pier Luigi; Jafari, Niusha; Birdu, Steven; Snyderu, Ellen; Gause, Christine; Braccou, Oswaldo L.; Pietanza, M. Catherine; Gruberu, Todd; Ribas, Antoni
errShare
errSave
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers
err2024-02-20
err2
errOAAI
errLin, Douglas I.; Huang, Richard S. P.; Ladas, Ioannis; Keller, Rachel B.; Patel, Nimesh R.; Lakis, Sotirios; Decker, Brennan; Janovitz, Tyler; Mata, Douglas A.; Ross, Jeffrey S.; Vergilio, Jo-Anne; Elvin, Julia A.; Herbst, Roy S.; Mack, Philip C.; Killian, Jonathan K.
errShare
errSave
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
err2024-01-01
err20
PREAI
errBorghaei, H.; de Marinis, F.; Dumoulin, D.; Reynolds, C.; Theelen, W. S. M. E.; Percent, I.; Calderon, V. Gutierrez; Johnson, M. L.; Madroszyk-Flandin, A.; Garon, E. B.; He, K.; Planchard, D.; Reck, M.; Popat, S.; Herbst, R. S.; Leal, T. A.; Shazer, R. L.; Yan, X.; Harrigan, R.; Peters, S.
errShare
errSave
SAPPHIRE: Phase III study of sitravatinib plus nivolumab versus docetaxel in patients with previously treated advanced non-squamous non-small cell lung cancer (NSCLC)
err2023-10-01
err0
PREAI
errBorghaei, H.; Johnson, M. L.; Garon, E. B.; He, K.; Planchard, D.; Reck, M.; Popat, S.; Herbst, R. S.; Leal, T. A.; Dumoulin, D.; De Marinis, F.; Reynolds, C. H.; Theelen, W. S. M. E.; Percent, I.; Calderon, V. Gutierrez; Flandin, A. C. Madroszyk; Shazer, R. L.; Yan, X.; Harrigan, R.; Peters, S.
errShare
errSave
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
err2023-07-13
err215
PREAI
errTsuboi, Masahiro; Herbst, Roy S.; John, Thomas; Kato, Terufumi; Majem, Margarita; Grohe, Christian; Wang, Jie; Goldman, Jonathan W.; Lu, Shun; Su, Wu-Chou; de Marinis, Filippo; Shepherd, Frances A.; Lee, Ki Hyeong; Le, Nhieu Thi; Dechaphunkul, Arunee; Kowalski, Dariusz; Poole, Lynne; Bolanos, Ana; Rukazenkov, Yuri; Wu, Yi-Long
errShare
errSave